OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $1,774,201 Invested

2024

University of Arizona

Roberta Brinton, PhD

Expanding AD Biomarkers in NIA funded PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial

  • Funding Amount: $1,774,201
  • Organization Type: Academic/Nonprofit
  • Program: Prevention
  • Target: Tau
  • Status: Active